10579-65-4 Usage
Description
1-(3,4-dihydroisoquinolin-2(1H)-yl)-3-phenylprop-2-en-1-one is a complex chemical compound characterized by the presence of a dihydroisoquinoline ring and a phenylpropenone group. It is recognized for its potential pharmacological and therapeutic properties, which make it a valuable subject of study in pharmaceutical research and development.
Uses
Used in Pharmaceutical Research and Development:
1-(3,4-dihydroisoquinolin-2(1H)-yl)-3-phenylprop-2-en-1-one is used as a compound of interest for its potential antitumor, anti-inflammatory, and antimicrobial effects. 1-(3,4-dihydroisoquinolin-2(1H)-yl)-3-phenylprop-2-en-1-one's unique structure and biological activities suggest that it may contribute to the development of new drugs and therapies for a range of medical conditions.
Used in Anticancer Applications:
While not explicitly mentioned in the provided materials, given the compound's potential antitumor properties, it could be used as an anticancer agent. Further research may reveal its effectiveness in targeting specific cancer cells or in combination with other treatments to enhance their efficacy.
Used in Anti-Inflammatory Applications:
Similarly, the anti-inflammatory potential of 1-(3,4-dihydroisoquinolin-2(1H)-yl)-3-phenylprop-2-en-1-one could make it a candidate for use in the development of treatments for inflammatory diseases, where it may help to reduce inflammation and associated symptoms.
Used in Antimicrobial Applications:
The antimicrobial properties of this compound suggest its potential use in the development of new antibiotics or antifungal agents, which could be crucial in the fight against drug-resistant infections.
Check Digit Verification of cas no
The CAS Registry Mumber 10579-65-4 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,0,5,7 and 9 respectively; the second part has 2 digits, 6 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 10579-65:
(7*1)+(6*0)+(5*5)+(4*7)+(3*9)+(2*6)+(1*5)=104
104 % 10 = 4
So 10579-65-4 is a valid CAS Registry Number.
10579-65-4Relevant articles and documents
Design, synthesis and evaluation of cinnamic acid hybrids as multi-target-directed agents for the treatment of Alzheimer's disease
Wang, Keren,Shi, Jian,Zhou, Yi,He, Ying,Mi, Jing,Yang, Jing,Liu, Shuang,Tang, Xiangcheng,Liu, Wenmin,Tan, Zhenghuai,Sang, Zhipei
, (2021/05/03)
Herein, combining 1,2,3,4-tetrahydroisoquinoline and benzylpiperidine groups into cinnamic acid derivatives, a series of novel cinnamic acid hybrids was rationally designed, synthesized and evaluated by the multi-target-directed ligands (MTDLs) strategy.
METHOD FOR SYNTHESISING AMIDES
-
Page/Page column 46-47, (2018/03/06)
The present invention relates to a method for synthesising amides that is of general applicability. The method may be performed in vitro or in vivo. Cell lines for use in the in vivo methods also form aspects of the invention. The method for synthesising a non-natural amide comprises: a. reaction of a carboxylic acid with a naturally occurring CoA ligase or a variant thereof; and b. reaction of the product of step a with an amine in the presence of a naturally occurring acyltransferase or a variant thereof; with the proviso that where the CoA ligase and acyltransferase are both naturally occurring, they are not derived from the same source species and do not act sequentially in a metabolic pathway; and with the proviso that the non-natural product is not N-(E)-p-coumaroyl-3-hydroxyanthranilic acid or N-(E)-p-caffeoyl-3-hydroxyanthranilic acid. Further, a method for producing an active pharmaceutical ingredient by the aforementioned method and host cells for carrying out said methods are envisaged.
